206 related articles for article (PubMed ID: 29969592)
1. The highly selective 5-HT
Hamadjida A; Nuara SG; Bédard D; Gaudette F; Beaudry F; Gourdon JC; Huot P
Neuropharmacology; 2018 Sep; 139():61-67. PubMed ID: 29969592
[TBL] [Abstract][Full Text] [Related]
2. 5-HT
Kwan C; Frouni I; Bédard D; Nuara SG; Gourdon JC; Hamadjida A; Huot P
Exp Brain Res; 2019 Feb; 237(2):435-442. PubMed ID: 30443669
[TBL] [Abstract][Full Text] [Related]
3. Combined 5-HT
Kwan C; Frouni I; Nuara SG; Belliveau S; Kang W; Hamadjida A; Bédard D; Beaudry F; Panisset M; Gourdon JC; Huot P
Neuropharmacology; 2021 Mar; 186():108465. PubMed ID: 33485945
[TBL] [Abstract][Full Text] [Related]
4. Additive effects of mGluR
Nuara SG; Gourdon JC; Maddaford S; Huot P
Naunyn Schmiedebergs Arch Pharmacol; 2021 Dec; 394(12):2381-2388. PubMed ID: 34550406
[TBL] [Abstract][Full Text] [Related]
5. Effect of the selective 5-HT
Frouni I; Kwan C; Bédard D; Belliveau S; Bourgeois-Cayer É; Gaudette F; Beaudry F; Hamadjida A; Huot P
Exp Brain Res; 2019 Jan; 237(1):29-36. PubMed ID: 30298296
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effects of the mGlu
Nuara SG; Gourdon JC; Huot P
Pharmacol Rep; 2022 Aug; 74(4):614-625. PubMed ID: 35761013
[TBL] [Abstract][Full Text] [Related]
7. Nefazodone reduces dyskinesia, but not psychosis-like behaviours, in the parkinsonian marmoset.
Hamadjida A; Nuara SG; Bédard D; Frouni I; Kwan C; Gourdon JC; Huot P
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1339-1345. PubMed ID: 30088028
[TBL] [Abstract][Full Text] [Related]
8. Selective metabotropic glutamate receptor 2 positive allosteric modulation alleviates L-DOPA-induced psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset.
Sid-Otmane L; Hamadjida A; Nuara SG; Bédard D; Gaudette F; Gourdon JC; Michaud V; Beaudry F; Panisset M; Huot P
Eur J Pharmacol; 2020 Apr; 873():172957. PubMed ID: 32004527
[TBL] [Abstract][Full Text] [Related]
9. Effect of the glycine transporter 1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset.
Frouni I; Belliveau S; Maddaford S; Nuara SG; Gourdon JC; Huot P
Eur J Pharmacol; 2021 Nov; 910():174452. PubMed ID: 34480885
[TBL] [Abstract][Full Text] [Related]
10. Trazodone alleviates both dyskinesia and psychosis in the parkinsonian marmoset model of Parkinson's disease.
Hamadjida A; Nuara SG; Gourdon JC; Huot P
J Neural Transm (Vienna); 2018 Sep; 125(9):1355-1360. PubMed ID: 29247391
[TBL] [Abstract][Full Text] [Related]
11. The 5-HT
Kwan C; Frouni I; Bédard D; Hamadjida A; Nuara SG; Gourdon JC; Huot P
Eur J Neurosci; 2024 Mar; 59(6):1169-1176. PubMed ID: 37515363
[TBL] [Abstract][Full Text] [Related]
12. Activation of mGlu
Frouni I; Hamadjida A; Kwan C; Bédard D; Nafade V; Gaudette F; Nuara SG; Gourdon JC; Beaudry F; Huot P
Neuropharmacology; 2019 Nov; 158():107725. PubMed ID: 31351976
[TBL] [Abstract][Full Text] [Related]
13. Effect of the mGlu
Frouni I; Kwan C; Bédard D; Kang W; Hamadjida A; Nuara SG; Gourdon JC; Huot P
Psychopharmacology (Berl); 2023 Oct; 240(10):2093-2099. PubMed ID: 37516708
[TBL] [Abstract][Full Text] [Related]
14. The effect of mirtazapine on dopaminergic psychosis and dyskinesia in the parkinsonian marmoset.
Hamadjida A; Nuara SG; Veyres N; Frouni I; Kwan C; Sid-Otmane L; Harraka MJ; Gourdon JC; Huot P
Psychopharmacology (Berl); 2017 Mar; 234(6):905-911. PubMed ID: 28130646
[TBL] [Abstract][Full Text] [Related]
15. The highly-selective 5-HT(1A) agonist F15599 reduces L-DOPA-induced dyskinesia without compromising anti-parkinsonian benefits in the MPTP-lesioned macaque.
Huot P; Johnston TH; Fox SH; Newman-Tancredi A; Brotchie JM
Neuropharmacology; 2015 Oct; 97():306-11. PubMed ID: 26071982
[TBL] [Abstract][Full Text] [Related]
16. Selective blockade of the 5-HT
Kwan C; Nuara SG; Bédard D; Gaudette F; Gourdon JC; Beaudry F; Huot P
Neuropharmacology; 2021 Jan; 182():108386. PubMed ID: 33152452
[TBL] [Abstract][Full Text] [Related]
17. Effect of the mGlu
Frouni I; Kwan C; Nuara SG; Belliveau S; Kang W; Hamadjida A; Bédard D; Gourdon JC; Huot P
J Neural Transm (Vienna); 2021 Jan; 128(1):73-81. PubMed ID: 33392826
[TBL] [Abstract][Full Text] [Related]
18. Monoamine oxidase A inhibition with moclobemide enhances the anti-parkinsonian effect of L-DOPA in the MPTP-lesioned marmoset.
Hamadjida A; Nuara SG; Kwan C; Frouni I; Bédard D; Gourdon JC; Huot P
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2157-2164. PubMed ID: 32621059
[TBL] [Abstract][Full Text] [Related]
19. UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances L-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset.
Huot P; Johnston TH; Lewis KD; Koprich JB; Reyes MG; Fox SH; Piggott MJ; Brotchie JM
Neuropharmacology; 2014 Jul; 82():76-87. PubMed ID: 24447715
[TBL] [Abstract][Full Text] [Related]
20. The selective 5-HT
Fisher R; Hikima A; Morris R; Jackson MJ; Rose S; Varney MA; Depoortere R; Newman-Tancredi A
Neuropharmacology; 2020 May; 167():107997. PubMed ID: 32057799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
